Scolaris Content Display Scolaris Content Display

مداخلات تغییر سیستم برای ترک سیگار

Contraer todo Desplegar todo

Referencias

Cabezas 2011 {published data only}

Cabezas C, Advani M, Puente D, Rodriguez‐Blanco T, Martin C: ISTAPS Study Group. Effectiveness of a stepped primary care smoking cessation intervention: Cluster randomized clinical trial (ISTAPS study). Addiction 2011;106(9):1696‐706. CENTRAL

Gordon 2010 {published data only}

Gordon JS, Andrews JA, Albert DA, Crews KM, Payne TJ, Severson HH. Tobacco cessation via public dental clinics: results of a randomized trial. American Journal of Public Health 2010;100(7):1307‐12. CENTRAL

Joseph 2004 {published data only}

Joseph MA, Arikian NJ, An LC, Nugent SM, Sloan RJ, Pieper CF. Results of a randomized controlled trial of intervention to implement smoking guidelines in Veterans Affairs medical centers: increased use of medications without cessation benefit. Medical Care 2004;42(11):1100‐10. CENTRAL

Little 2009 {published data only}

Little SJ, Hollis JF, Fellows JL, Snyder JJ, Dickerson JF. Implementing a tobacco assisted referral program in dental practices. Journal of Public Health Dentistry 2009;69(3):149‐55. CENTRAL

Patwardhan 2012 {published data only}

Patwardhan PD, Chewning BA. Effectiveness of intervention to implement tobacco cessation counseling in community chain pharmacies. Journal of the American Pharmacists Association 2012;52(4):507‐14. CENTRAL

Rothemich 2010 {published data only}

Rothemich SF, Woolf SH, Johnson RE, Devers KJ, Flores SK, Villars P, et al. Promoting primary care smoking‐cessation support with quitlines: the QuitLink randomized controlled trial. American Journal of Preventive Medicine 2010;38(4):367‐74. CENTRAL

Winickoff 2014 {published data only}

Winickoff JP, Nabi‐Burza E, Chang Y, Regan S, Drehmer J, Finch S, et al. Implementation of a parental tobacco control intervention in pediatric practice. Pediatrics 2014;132(1):109‐17. CENTRAL

Althabe 2013 {published data only}

Althabe F, Aleman A, Mazzoni A, Berrueta M, Morello P, Colomar M, et al. Tobacco cessation intervention for pregnant women in Argentina and Uruguay: Study protocol. Reproductive Health 2013;10(1):44. CENTRAL

Amemori 2013 {published data only}

Amemori M, Virtanen J, Korhonen T, Kinnunen TH, Murtomaa H. Impact of educational intervention on implementation of tobacco counselling among oral health professionals: a cluster‐randomized community trial. Community Dentistry and Oral Epidemiology 2013;41(2):120‐9. CENTRAL

Anders 2011 {published data only}

Anders ME, Sheffer CE, Barone CP, Holmes TM, Simpson DD, Duncan AM. Emergency department‐initiated tobacco dependence treatment. American Journal of Health Behavior 2011;35(5):546‐56. CENTRAL

Bentz 2007 {published data only}

Bentz CJ, Bayley KB, Bonin KE, Fleming L, Hollis JF, Hunt JS, et al. Provider feedback to improve 5A's tobacco cessation in primary care: a cluster randomized clinical trial. Nicotine & Tobacco Research 2007;9(3):341‐9. CENTRAL

Campbell 2006 {published data only}

Campbell E, Walsh RA, Sanson‐Fisher R, Burrows S, Stojanovski E. A group randomised trial of two methods for disseminating a smoking cessation programme to public antenatal clinics: effects on patient outcomes. Tobacco Control 2006;15(2):97‐102. CENTRAL

Coleman 2007 {published data only}

Coleman T, Lewis S, Hubbard R, Smith C. Impact of contractual financial incentives on the ascertainment and management of smoking in primary care. Addiction 2007;102(5):803‐8. CENTRAL

Cooke 2001 {published data only}

Cooke M, Mattick RP, Walsh RA. Differential uptake of a smoking cessation programme disseminated to doctors and midwives in antenatal clinics. Addiction 2001;96(3):495‐505. CENTRAL

Cummings 1989 {published data only}

Cummings SR, Coater TJ, Richard RJ, Hansen B, Zahnd EG, VanderMartin R, et al. Training physicians in counseling about smoking cessation. A randomized trial of the 'Quit for Life' program. Annals of Internal Medicine 1989;110(8):640‐7. CENTRAL

Davies 2005 {published data only}

Davies SL, Kohler CL, Fish L, Taylor BE, Foster GE, Annang L. Evaluation of an intervention for hospitalized African American smokers. American Journal of Health Behavior 2005;29(3):228‐39. CENTRAL

Fellows 2012 {published data only}

Fellows JL, Mularski R, Waiwaiole L, Funkhouser K, Mitchell J, Arnold K, et al. Health and economic effects from linking bedside and outpatient tobacco cessation services for hospitalized smokers in two large hospitals: study protocol for a randomized controlled trial. Trials 2012;13:129. CENTRAL

Ferketich 2014 {published data only}

Ferketich AK, Pennell M, Seiber EE, Wang L, Farietta T, Jin Y, et al. Provider‐delivered tobacco dependence treatment to medicaid smokers. Nicotine & Tobacco Research 2014;16(6):786‐93. CENTRAL

Fisher 2005 {published data only}

Fisher E, Musick J, Scott C, Miller JP, Gram R, Richardson V, et al. Improving clinic‐ and neighborhood‐based smoking cessation services within federally qualified health centers serving low‐income, minority neighborhoods. Nicotine & Tobacco Research 2005;7 Suppl 1:S45‐56. CENTRAL

Freund 2009 {published data only}

Freund M, Campbell E, Paul C, Sakrouge R, Lecathelinais C, Knight J, et al. Increasing hospital‐wide delivery of smoking cessation care for nicotine‐dependent in‐patients: a multi‐strategic intervention trial. Addiction 2009;104(5):839‐49. CENTRAL

Hennrikus 2005 {published data only}

Hennrikus DJ, Lando HA, McCarty MC, Klevan D, Holtan N, Huebsch JA, et al. The TEAM project: the effectiveness of smoking cessation intervention with hospital patients. Preventive Medicine 2005;40(3):249‐58. CENTRAL

Katz 2004 {published data only}

Katz DA, Muehlenbruch DR, Brown RL, Fiore MC, Baker TB. Effectiveness of implementing the Agency for Healthcare Research and Quality Smoking Cessation Clinical Practice Guideline: A randomized, controlled trial. Journal of the National Cancer Institute 2004;96(8):594‐603. CENTRAL

Kendrick 1995 {published data only}

Kendrick JS, Zahniser SC, Miller N, Salas N, Stine J, Gargiullo PM, et al. Integrating smoking cessation into routine public prenatal care: the Smoking Cessation in Pregnancy project. American Journal of Public Health 1995;85(2):217‐22. CENTRAL

Kim 2005 {published data only}

Kim JR, Lee MS, Hwang JY, Lee JD. Efficacy of a smoking cessation intervention using the AHCPR guideline tailored for Koreans: A randomized controlled trial. Health Promotion International 2005;20(1):51‐9. CENTRAL

Mahabee‐Gittens 2008 {published data only}

Mahabee‐Gittens ME, Gordon JS, Krugh ME, Henry B, Leonard AC. A smoking cessation intervention plus proactive quitline referral in the pediatric emergency. Nicotine & Tobacco Research 2008;10(12):1745‐51. CENTRAL

Maizlish 2006 {published data only}

Maizlish NA, Ruland J, Rosinski ME, Hendry K. A systems‐based intervention to promote smoking as a vital sign in patients served by community health centers. American Journal of Medical Quality 2006;21(3):169. CENTRAL

Manfredi 1999 {published data only}

Manfredi C, Crittenden KS, Warnecke R, Engler J, Cho YI, Shaligram C. Evaluation of a motivational smoking cessation intervention for women in public health clinics. Preventive Medicine 1999;28(1):51‐60. CENTRAL

Manfredi 2000 {published data only}

Manfredi C, Crittenden KS, Cho YI, Engler J, Warnecke R. The effect of a structured smoking cessation program, independent of exposure to existing interventions. American Journal of Public Health 2000;90(5):751‐6. CENTRAL

Manfredi 2004 {published data only}

Manfredi C, Crittenden KS, Cho YI, Gao S. Long‐term effects (up to 18 months) of a smoking cessation program among women smokers in public health clinics. Preventive Medicine 2004;38(1):10‐9. CENTRAL

Manfredi 2011 {published data only}

Manfredi C, Cho YI, Warnecke R, Saunders S, Sullivan M. Dissemination strategies to improve implementation of the PHS smoking cessation guideline in MCH public health clinics: experimental evaluation results and contextual factors. Health Education Research 2011;26(2):348‐60. CENTRAL

McFall 2010 {published data only}

McFall M, Saxon AJ, Malte CA, Chow B, Bailey S, Baker DG, et al. Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial. JAMA 2010;304(22):2485‐93. CENTRAL

Murray 2013 {published data only}

Murray R, Leonardi‐Bee J, Marsh J, Jayes L, Li J, Parrott S, et al. Systematic identification and treatment of smokers by hospital based cessation practitioners in a secondary care setting: cluster randomised controlled trial. BMJ 2013;347:f4004. CENTRAL

Pbert 2004 {published data only}

Pbert L, Ockene JK, Zapka J, Ma Y, Goins KV, Oncken C, et al. A community health center smoking‐cessation intervention for pregnant and postpartum women. American Journal of Preventive Medicine 2004;26(5):377‐85. CENTRAL

Rindal 2013 {published data only}

Rindal DB, Rush WA, Schleyer TKL, Kirshner M, Boyle RG, Thoele MJ, et al. Computer‐assisted guidance for dental office tobacco‐cessation counseling: a randomized controlled trial. American Journal of Preventive Medicine 2013;44(3 Suppl 3):260‐4. CENTRAL

Roski 1998 {published data only}

Roski J. Changing practice patterns as a result of implementing the Agency for Health Care Policy and Research guideline in 20 primary care clinics. Tobacco Control 1998;7 Suppl:S19‐20; discussion S4‐5. CENTRAL

Sherman 2008 {published data only}

Sherman SE, Takahashi N, Kalra P, Gifford E, Finney JW, Canfield J, et al. Care coordination to increase referrals to smoking cessation telephone counseling: A demonstration project. American Journal of Managed Care 2008;14(3):141‐8. CENTRAL

Szatkowski 2016 {published data only}

Szatkowski L, Aveyard P. Provision of smoking cessation support in UK primary care: impact of the 2012 QOF revision. British Journal of General Practice 2016;66(642):10‐5. CENTRAL

Szpunar 2006 {published data only}

Szpunar SM, Williams PD, Dagroso D, Enberg RN, Chesney JD. Effects of the tobacco use cessation automated clinical practice guideline. American Journal of Managed Care 2006;12(11):665‐73. CENTRAL

Taggar 2012 {published data only}

Taggar JS, Coleman T, Lewis S, Szatkowski L. The impact of the Quality and Outcomes Framework (QOF) on the recording of smoking targets in primary care medical records: cross‐sectional analyses from The Health Improvement Network (THIN) database. BMC Public Health 2012;12:329. CENTRAL

Thomas 2016 {published data only}

Thomas D, Abramson MJ, Bonevski B, Taylor S, Poole SG, Paul E, et al. Integrating smoking cessation into routine care in hospitals ‐‐ a randomized controlled trial. Addiction 2016;111(4):14‐23. CENTRAL

Unrod 2007 {published data only}

Unrod M, Smith M, Spring B, DePue J, Redd W, Winkel G. Randomized controlled trial of a computer‐based, tailored intervention to increase smoking cessation counseling by primary care physicians. Journal of General Internal Medicine 2007;22(4):478‐84. CENTRAL

Vidrine 2013a {published data only}

Vidrine JI, Shete S, Cao Y, Greisinger A, Harmonson P, Sharp B, et al. Ask‐Advise‐Connect: A new approach to smoking treatment delivery in health care settings. JAMA Internal Medicine 2013;173(6):458‐64. CENTRAL

Vidrine 2013b {published data only}

Vidrine JI, Shete S, Li Y, Cao Y, Alford MH, Galindo‐Talton M, et al. The ask‐advise‐connect approach for smokers in a safety net healthcare system: A group‐randomized trial. American Journal of Preventive Medicine 2013;45(6):737‐41. CENTRAL

Walsh 1997 {published data only}

Walsh RA, Redman S, Brinsmead MW, Byrne JM, Melmeth A. A smoking cessation program at a public antenatal clinic. American Journal of Public Health 1997;87(7):1201‐4. CENTRAL

Wolfenden 2005 {published data only}

Wolfenden L, Wiggers J, Knight J, Campbell E, Spigelman A, Kerridge R, et al. Increasing smoking cessation care in a preoperative clinic: a randomized controlled trial. Preventive Medicine 2005;41(1):284‐90. CENTRAL

Yano 2008 {published data only}

Yano EM, Rubenstein LV, Farmer MM, Chernof BA, Mittman BS, Lanto AB, et al. Targeting primary care referrals to smoking cessation clinics does not improve quit rates: implementing evidence‐based interventions into practice. Health Services Research 2008;43(5 P1):1637‐61. CENTRAL

Bonevski 2016 {published data only}

Bonevski B, Guillaumier A, Shakeshaft A, Farrell M, Tzelepis F, Walsberger S, et al. An organisational change intervention for increasing the delivery of smoking cessation support in addiction treatment centres: study protocol for a randomized controlled trial. Trials 2016;17(1):290. CENTRAL

Ostroff 2014 {published data only}

Ostroff JS, Li Y, Shelley DR. Dentists United to Extinguish Tobacco (DUET): a study protocol for a cluster randomized, controlled trial for enhancing implementation of clinical practice guidelines for treating tobacco dependence in dental care settings. Implementation Science 2014;9:25. CENTRAL

AHCPR 1996

Fiore MC, Wetter DW, Bailey WC, Bennett G, Cohen SJ, Dorfman SF, Goldstein MG, Gritz ER, Hasselblad V, Henningfield JE. The Agency for Health Care Policy and Research Smoking Cessation Clinical Practice Guideline. JAMA 1996;275(16):1270‐80.

AHRQ 2012

Agency for Healthcare Research and Quality. Systems Change: Treating Tobacco Use and Dependence: Based on the Public Health Service (PHS) Clinical Practice Guideline—2008 Update. www.ahrq.gov/professionals/clinicians‐providers/guidelines‐recommendations/tobacco/decisionmakers/systems/index.html December 2012 (Accessed 25 January 2017).

Aquilino 2003

Aquilino ML, Farris KB, Zillich AJ, Lowe JB. Smoking‐cessation services in Iowa community pharmacies. Pharmacotherapy 2003;23(5):666‐73.

Braun 2004

Braun BL, Fowles JB, Solberg LI, Kind EA, Lando H, Pine D. Smoking‐related attitudes and clinical practices of medical personnel in Minnesota. American Journal of Preventive Medicine 2004;27(4):316‐22.

Critchley 2012

Critchley JA, Capewell S. Smoking cessation for the secondary prevention of coronary heart disease. Cochrane Database of Systematic Reviews 2012, Issue 2. [DOI: 10.1002/14651858.CD003041]

Ebbert 2005

Ebbert JO, Williams BA, Sun Z, Aubry MC, Wampfler JA, Garces YI, et al. Duration of smoking abstinence as a predictor for non‐small‐cell lung cancer survival in women. Lung Cancer 2005;47(2):165‐72.

Fiore 2007

Fiore MC, Keller PA, Curry SJ. Health system changes to facilitate the delivery of tobacco‐dependence treatment. American Journal of Preventive Medicine 2007;33(6 Suppl):S349‐56.

Fiore 2008

Fiore MC, Jaén CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. U.S. Department of Health and Human Services. Public Health ServiceMay 2008.

Freund 2005

Freund M, Campbell E, Paul C, Sakrouge R, Wiggers J. Smoking care provision in smoke‐free hospitals in Australia. Preventive Medicine 2005;41(1):151‐8.

Freund 2008

Freund M, Campbell E, Paul C, McElduff P, Walsh RA, Sakrouge R, et al. Smoking care provision in hospitals: a review of prevalence. Nicotine & Tobacco Research 2008;10(5):757‐74.

Higgins 2011

Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.

Hudson 2010

Hudson NL, Mannino DM. Smoking as a chronic disease. Journal of Community Health 2010;35(5):549‐53.

Levy 2004

Levy DT, Chaloupka F, Gitchell J. The effects of tobacco control policies on smoking rates: a tobacco control scorecard. Journal of Public Health Management and Practice 2004;10(4):338‐53.

Peto 2000

Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case‐control studies. BMJ 2000;321(7257):323‐9.

Revell 2005

Revell CC, Schroeder SA. Simplicity matters: using system‐level changes to encourage clinician intervention in helping tobacco users quit. Nicotine & Tobacco Research 2005;7 Suppl 1:S67‐69.

Taylor 2002

Taylor DH, Hasselblad V, Henley SJ, Thun MJ, Sloan FA. Benefits of smoking cessation for longevity. American Journal of Public Health 2002;92(6):990‐6.

Thorndike 1998

Thorndike AN, Rigotti NA, Stafford RS, Singer DE. National patterns in the treatment of smokers by physicians. JAMA 1998;279(8):604‐8.

Wagner 1998

Wagner EH. Chronic disease management: what will it take to improve care for chronic illness?. Effective Clinical Practice 1998;1(1):2‐4.

West 2005

West R, Hajek P, Stead L, Stapleton J. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction 2005;100(3):299‐303.

WHO 2011

Worl Health Organization. WHO Report on the Global Tobacco Epidemic: Warning about the Dangers of Tobacco. apps.who.int/iris/bitstream/10665/44616/1/9789240687813_eng.pdf. Geneva, 2011 (Accessed 25 January 2017).

Winickoff 2013

Winickoff JP, Nabi‐Burza E, Chang Y, Finch S, Regan S, Wasserman R, et al. Implementation of a parental tobacco control intervention in pediatric practice. Pediatrics 2013;132(1):109‐17.

Wolfenden 2009

Wolfenden L, Wiggers J, Campbell E, Knight J, Kerridge R, Spigelman A. Providing comprehensive smoking cessation care to surgical patients: the case for computers. Drug and Alcohol Review 2009;28(1):60‐5.

Thomas 2013

Thomas D, Abramson MJ, Bonevski B, George J. System change interventions for smoking cessation. Cochrane Database of Systematic Reviews 2013, Issue 9. [DOI: 10.1002/14651858.CD010742]

Characteristics of studies

Characteristics of included studies [ordered by study ID]

Cabezas 2011

Methods

Design: Cluster‐randomized clinical trial

Setting: 176 Primary Care Centres (PCCs) in Spain

Intervention providers: Physicians and nurses

Data collection: Baseline survey at the clinic and then telephone follow‐up interviews

Study duration: 24 months follow‐up (study conducted between 2003 and 2005)

Participants

2827 participants, age (mean ± SD) 42.8 ± 13.6 years, 50.0% men, cigarettes per day (mean ± SD) 20.4 ± 10.8

Intervention group: 1345 people from 82 PCCs; control group: 1482 people from 94 PCCs

Interventions

1) Intervention

  • Identification of smokers: All individuals accessing the PCC were asked about their smoking status. The method of documentation of smoking status was not described

  • Training/resources/feedback: All health professionals received 20 hours of training; no feedback was provided

  • Dedicated staff for smoking cessation treatment: Not included

  • Promote hospital policies that support smoking cessation: None mentioned

  • Tobacco dependence treatment: Tailored intervention based on 'stages of change’

    • Pre‐contemplation and contemplation: brief motivational intervention plus self‐help leaflet

    • Preparation and action (not interested in support): brief advice, self‐help leaflet, offer/prescription of NRT and 1 follow‐up

    • Preparation and action (interested in support): Intensive intervention consisting of 9 follow‐up visits over 6 months, consisting of behavioural and pharmacological support (NRT or bupropion) and self‐help leaflet

    • Maintenance stage: reinforcement advice

  • Reimbursement to clinicians: Not included

2) Control: Usual care that included brief quitting advice for disease related to smoking. Some control group smokers used cessation medications

Outcomes

1‐year continuous abstinence at 2‐year follow‐up

6 months continuous abstinence at 2‐year follow‐up

6 months continuous abstinence at 1‐year follow‐up

Point prevalence abstinence at 2‐year follow‐up

Point prevalence abstinence at 1‐year follow‐up

Notes

The study was conducted with financial help from the Spanish Preventive Services Network granted by the Carlos III Health Institute. The authors state that they have no conflict of interest to declare.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Independent statistician blinded to the sites' identities generated random sequence using a computer programme

Allocation concealment (selection bias)

Low risk

Centralized randomization, PCCs were informed about their allocation only after giving final consent

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Not feasible with the study design

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

The clinical part of the questionnaire was administered by the clinicians involved in the study and non‐clinical part was administered by a blinded interviewer

Incomplete outcome data (attrition bias)
All outcomes

Low risk

43.3% in the intervention and 44.8% in the control group lost to follow‐up, included as smokers. Similar dropout rate in both groups

Selective reporting (reporting bias)

Low risk

The study protocol is available and all of the prespecified outcomes that are of interest in the review have been reported in the prespecified way

Other bias

High risk

Only 37.3% ex‐smokers confirmed their smoking status biochemically

Gordon 2010

Methods

Design: Cluster‐randomized clinical trial

Setting: 14 community health centre dental clinics in 3 states in the USA

Intervention providers: Dentists, dental hygienists and dental assistants

Data collection: Baseline survey at the clinic and then mailed follow‐up survey

Study duration: 7.5 months follow‐up (study conducted between 2005 and 2008)

Participants

2549 participants, aged (mean ± SD) 40.5 ± 12.6 years, 42.8% men, average cigarettes per day (mean ± SD) 16.1 ± 10.4.
Intervention group: 1394 people; control group: 1155 people

Interventions

1) Intervention (based on 5As)

  • Identification of smokers: asked tobacco use status of all participants at every clinic visit. The method of documentation of smoking status was not described

  • Training/resources/feedback: Intervention providers received a 3‐hour in‐service workshop; resources such as nicotine patches/lozenges and printed self‐help materials were provided to each practice to facilitate the 'assist' component; feedback was not part of the intervention

  • Dedicated staff for smoking cessation treatment: Not included

  • Promote hospital policies that support smoking cessation: None mentioned

  • Tobacco dependence treatment: Intervention consisted of:

    • Asking all participants about smoking, advising them to quit by relating the oral effects of smoking to their oral health status and assessing their readiness to quit

    • Interested smokers were assisted with setting a quit date, use of pharmacotherapy, and received free NRT and self‐help materials

    • Arrange follow‐up: Participants who set a quit date received follow‐up support (mail or phone)

  • Reimbursement to clinicians: Not included

2) Control: Practitioners in the control group continued to provide usual care

Outcomes

7‐day point prevalence abstinence and prolonged abstinence at 6 weeks and 7½ months follow‐up

Notes

The study was supported by the National Institutes of Health, National Cancer Institute. No conflict of interest declaration was included in the manuscript.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Method of randomization not specified

Allocation concealment (selection bias)

Unclear risk

Not described

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Not described

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

No blinding of outcome assessment, but the authors have judged that the outcome assessment is not likely to be biased, as a mail survey was used to collect follow‐up data

Incomplete outcome data (attrition bias)
All outcomes

High risk

Higher dropout rate in intervention group (30.7% vs 26.1%; P < 0.01). Multiple imputation to replace missing data

Selective reporting (reporting bias)

Unclear risk

No published protocol

Other bias

High risk

No biochemical verification of smoking status

Joseph 2004

Methods

Design: Cluster‐randomized clinical trial

Setting: 20 Veterans Affairs medical centres (VAMCs) in the USA

Intervention providers: Physicians, nurses, psychologists and pharmacists

Data collection: Telephone survey among 3 cohorts of participants; 1) baseline cross‐sectional survey; 2) a second cross‐sectional survey 1 year after initiation of the intervention; and 3) follow‐up survey of smokers identified in the baseline survey; data were also collected from medical records

Study duration: 12 months follow‐up (the study dates are not reported in the manuscript)

Participants

  • Baseline survey: 4254 participants: 2112 intervention (mean age 64.6 years, 96.1% men, 22.6% current smokers and 53.8% ex‐smokers) and 2142 control (mean age 63.1 years, 95.3% men, 24.6% current smokers and 52.8% ex‐smokers).

  • Follow‐up survey: 575 smokers (280 intervention and 295 control) completed a follow‐up survey 1 year later.

  • Post‐intervention: 1424 participants: 641 intervention (mean age 64.9 years, 95.8% men, 24.0% current smokers and 48.7% ex‐smokers) and 783 control (mean age 63.8 years, 98.0% men, 24.7% current smokers and 50.7% ex‐smokers)

Interventions

1) Intervention

  • Identification of smokers: Various methods were used to identify smokers and document smoking status in the medical record. Strategies included ‘smoking as a vital sign’ approach, use of electronic reminder system and adaptation of note template to include smoking status

  • Training/resources/feedback: 2‐day training; no feedback was provided

  • Dedicated staff for smoking cessation treatment: Not present. The interventionist (a registered nurse trained in smoking cessation methods) made a 2‐ to 3‐day visit to each of the intervention sites during the first 6 months of the intervention period

  • Promote hospital policies that support smoking cessation: Increased the availability of pharmacotherapy

  • Tobacco dependence treatment: Promoted brief intervention and liberal use of smoking cessation medications

  • Reimbursement to clinicians: Not included

2) Control: provided 5 copies of AHCPR smoking cessation guideline to each control clinic

Outcomes

Cessation outcomes: Self‐reported smoking status at 1‐year follow‐up

Process outcomes: Improvement in documentation of tobacco use, delivery of treatment to all smokers, and use of pharmacotherapy collected by participant surveys and from medical records

Notes

This study was supported by a grant from the Veterans Administration Health Services Research and Development Service. No conflict of interest declaration was included in the manuscript.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

"The study sites (n=20) were randomly assigned to the intervention or control group using simple (not stratified or block) randomisation"

Allocation concealment (selection bias)

Low risk

"The remaining 20 sites were randomised." Presumably randomized all clusters at once

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Not described

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Blinded interviewer

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

Dropout rate by group not given

Selective reporting (reporting bias)

Unclear risk

No published protocol

Other bias

High risk

No biochemical verification of smoking status

Little 2009

Methods

Design: Cluster‐randomized clinical trial

Setting: 14 dental clinics in the USA

Intervention providers: Dentist, office staff and hygienist

Data collection: From electronic health records

Study duration: No follow‐up, 14 months data collection (study conducted between 2006 and 2007)

Participants

Electronic health record‐generated data (asking, advising and referral) included all people visiting the participating clinics which included 66,516 patients (32,802 intervention and 33,714 control)

Interventions

1) Intervention

  • Identification of smokers: Dental staff asked about tobacco use and documented smoking status in the electronic health record

  • Training/resources/feedback: Staff received a 2‐hour orientation and training. Brief refresher training was also included after the project began. Resources such as handouts and referral forms were stocked at each facility and identified a semiprivate area for making calls (to an outside smoking cessation clinic for further assistance). Monthly performance feedback at the provider, office and cross‐office levels was provided to intervention sites

  • Dedicated staff for smoking cessation treatment: A dedicated staff member was not present, but a core implementation group was established that included the project investigator, intervention director, study staff, health plan leaders, administrators and professional leaders of each of the intervention sites

  • Promote hospital policies that support smoking cessation: Changes were made to the standard visit encounter form and electronic dental record to facilitate tracking of smoking status and feedback to staff

  • Tobacco dependence treatment: It was a team approach in which the dental staff, usually the hygienist, asked about tobacco use and provided brief advice to quit. The dentist reinforced the importance of quitting and provided brief, clear and respectful advice to quit. The staff then encouraged smokers to talk briefly by telephone with a health plan tobacco counsellor. Smokers could either call from the dental office or request a call‐back option. The health plan counsellor also arranged cessation medications as part of their covered benefit

  • Reimbursement to clinicians: Not included

2) Control: Standard care

Outcomes

Number of participants counselled or referred, or both

Notes

Only secondary outcomes were evaluated. This study was supported by the National Institute of Drug Abuse. No conflict of interest declaration was included in the manuscript.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

"Matched pairs of facilities were then randomly assigned to intervention or control." Presumably did the randomization

Allocation concealment (selection bias)

Low risk

Presumably randomized all clusters at once

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Not specified

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Relevant data were generated from electronic health records (objective assessment)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No follow‐up involved

Selective reporting (reporting bias)

Unclear risk

No published protocol

Other bias

Low risk

Patwardhan 2012

Methods

Design: Cluster‐randomized clinical trial

Setting: 16 community chain pharmacies in the USA

Intervention providers: Pharmacists and technicians

Data collection: from pharmacy staff using feedback form. Staff were instructed to check off relevant items (asked, advised, provided quitline cards) for the activity performed. Referral data were obtained from quitline reports

Study duration: No follow‐up; 1 month data collection (study conducted between 2008 and 2009)

Participants

32 pharmacists and 48 technicians (No data collected from pharmacy clients; all data collected from pharmacy staff).

Interventions

1) Intervention

  • Identification of smokers: Technicians identified smokers by asking about their tobacco use and documented the status on a form which was attached to the prescription

  • Training/resources/feedback: 30 minutes on‐site training and a support visit from the research team in the first week of implementation; no feedback was provided

  • Dedicated staff for smoking cessation treatment: Not feasible with the setting

  • Promote clinic policies that support smoking cessation: Changed work‐flow to integrate Ask, Advice and Refer (AAR) component

  • Tobacco dependence treatment: Technicians asked about tobacco use and pharmacists subsequently advised tobacco users to quit and referred them to quitline. If smokers had already decided to quit, pharmacist did not advise them to quit, but instead referred them to quitline. Technicians faxed completed forms to quitline. Quitline services included free counselling and medications

  • Reimbursement to clinicians: Not included

2) Control: Control group pharmacies received an informal presentation on quitline services, quitline cards and enrolment in Fax to Quit (FTQ) services, a free service

Outcomes

Number of participants asked about tobacco use

Number of tobacco users advised to Quit

Number of tobacco users enrolled for quitline service

Number of quitline cards given

Notes

Data collected form the pharmacy staff. The study was supported by the Wisconsin department of Health Services; the Sonderegger Research Center, School of Pharmacy, University of Wisconsin–Madison; and Clinical and Translational Science Award program, National Center for Research Resources, National Institutes of Health. The authors state that they had no conflicts of interest to declare.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

"Sixteen pharmacies were randomly assigned to a control group or experimental group using block randomisation, which involved random assignment into groups after matching on a block covariate"

Allocation concealment (selection bias)

Low risk

"Random assignment was carried out by research assistants blinded to the study goal. The authors were not involved in the assignment process"

Blinding of participants and personnel (performance bias)
All outcomes

Low risk

Pharmacy staff were not aware of the existence of 2 groups in the study. The primary author who conducted staff training was blinded to pharmacists’ self‐efficacy scores

Blinding of outcome assessment (detection bias)
All outcomes

High risk

The outcome data were directly obtained from the providers using a self‐filled documentation form

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No follow‐up in the study

Selective reporting (reporting bias)

Unclear risk

No published protocol

Other bias

Low risk

Rothemich 2010

Methods

Design: Cluster‐randomized clinical trial

Setting: 16 primary care practices in the USA

Intervention providers: Physicians, nurses and medical assistants

Data collection: Participant self‐report via an exit survey

Study duration: No follow‐up; 9 months data collection (study conducted between 2005 and 2006)

Participants

All persons visiting the participating clinics which included 10,395 patients (5669 intervention and 4726 control). Tobacco user population: 1815 adult smokers (857 intervention and 958 control)

Interventions

1) Intervention

  • Identification of smokers: Identified and documented using an expanded tobacco use 'vital sign' stamp which also assessed the delivery of cessation advice and readiness to quit smoking in the next 30 days

  • Training/resources/feedback: 1‐hour training to implement study procedures. Quarterly performance feedback was provided to the intervention practices

  • Dedicated staff for smoking cessation treatment: Not present

  • Promote clinic policies that support smoking cessation: Implemented a vital sign stamp to identify and document smoking status

  • Tobacco dependence treatment: Fax referral of preparation‐stage smokers to quitline. Quitline offered 4 proactive telephone counselling sessions. When indicated, Quitline contacted participant’s physician to request a prescription of bupropion, the only prescription cessation medication covered by most health plans at the time of the study

  • Reimbursement to clinicians: Not included

2) Control: Traditional tobacco use vital sign stamp (only smoking status recorded)

Outcomes

Number of participants asked about tobacco use

Number of participants advised to quit

Number of participants received in‐office cessation support (primary end point)

Number of participants discussing ideas and plans to quit smoking

Number of participants referred to quitline

Notes

36% of potentially eligible people did not participate in the survey, but the participation proportion did not differ between study groups. This study was funded through a grant from the Agency for Healthcare Research and Quality. One author declares stock in a quitline service provider. No other disclosures were made.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

"A random number generator was used to randomise practices within the strata to intervention and control arms"

Allocation concealment (selection bias)

Low risk

"From the potential pool of 51 sites, 29 practices were targeted for recruitment and 16 were enrolled." Presumably randomized all clusters at once

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Not feasible with study design

Blinding of outcome assessment (detection bias)
All outcomes

High risk

No blinded outcome assessor

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No follow‐up in the study

Selective reporting (reporting bias)

Unclear risk

No published protocol

Other bias

Low risk

Winickoff 2014

Methods

Design: Cluster‐randomized clinical trial

Setting: 20 paediatric practices in the USA

Intervention providers: Paediatricians, nurses and medical assistants

Data collection: Telephone survey

Study duration: 12 months follow‐up (study conducted between 2010 and 2012)

Participants

1980 parent smokers;
Intervention: 999 smokers (average age 30 years ranged between 18 ‐ 78 years and 78.6% women) Control: 981 smokers (average age 30.6 years, ranged between 18 ‐ 65 years and 77.9% women)

Interventions

1) Intervention

  • Identification of smokers: Routine screening for parental tobacco use using a special action sheet and documentation in child's health record

  • Training/resources/feedback: All intervention providers attended approximately 3 hours of training; no feedback was provided.

  • Dedicated staff for smoking cessation treatment: Not present

  • Promote clinic policies that support smoking cessation: Incorporated a special action sheet to capture tobacco use status of the parents of paediatric patients and documented their smoking status in paediatric medical records

  • Tobacco dependence treatment: Ask, Assist and refer approach which included motivational messaging, recommendation and possible provision of NRT (nicotine patch or gum), and enrolment in the free quitline service

  • Reimbursement to clinicians: Not included

2) Control: Usual care

Outcomes

Biochemically validated parental smoking cessation rates

Number of parents asked about tobacco use

Number of parents advised and counselled to quit

Number of parents prescribed cessation medication

Number of parents referred to the state quitline

Notes

This study was supported the National Institute of Health. One author declares work as an unpaid consultant for a pharmaceutical company. No other disclosures to report.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

"A random generator was used to generate a sequence of group assignments within each of the 6 blocks created by combining the 2 strata"

Allocation concealment (selection bias)

Low risk

"The first 22 practices that responded were enrolled and randomly assigned to intervention or control groups." Presumably randomised all clusters at once

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Not described

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Not described

Incomplete outcome data (attrition bias)
All outcomes

High risk

Although not statistically significant, the follow‐up rate was marginally higher in the control group (64.5% vs 72.4%; P = 0.11) and hence considered as high risk of bias

Selective reporting (reporting bias)

Unclear risk

No published protocol

Other bias

Low risk

Characteristics of excluded studies [ordered by study ID]

Study

Reason for exclusion

Althabe 2013

Only midwives are involved in the program

Amemori 2013

3‐arm study comparing 2 types of interventions (education only vs education plus fee‐for‐service) with a control group; No evidence of organization‐wide involvement, and no identification or treatment components. The remuneration was provided only during the 6‐month study period

Anders 2011

Only non‐urgent emergency department patients were targeted

Bentz 2007

Evaluating the effect of electronic health record‐generated provider feedback to improve 5As delivery (only feedback introduced; no other components). Only GPs are targeted

Campbell 2006

Comparing 2 methods of disseminating a smoking cessation programme; Not a system initiated change; no effort to improve identification or treatment component

Coleman 2007

Implemented only the reimbursement (pay‐for‐performance) component of the system change intervention and targeted only GPs

Cooke 2001

Comparing 2 methods of disseminating a smoking cessation programme; Not a system initiated change; no effort to improve identification or treatment component

Cummings 1989

Only training implemented

Davies 2005

Included hospitalized African‐American smokers only

Fellows 2012

Only smokers interested in remaining abstinent after discharge and living within 50 miles of the participating hospital were included in the study

Ferketich 2014

Only Medicaid‐enrolled smokers were included in the study; research assistant identified participants, not clinic staff

Fisher 2005

Controlled before‐and‐after study, not meeting study design requirements

Freund 2009

Controlled before‐and‐after study, not meeting study design requirements

Hennrikus 2005

Research assistants identified smokers

Katz 2004

Telephone follow‐up counselling was done by a researcher

Kendrick 1995

No evidence of effort to identify and treat all smokers accessing the system. Interventions were different at various sites

Kim 2005

Only those randomized to the intervention arm received assistance and follow‐up support, which were provided by a researcher; tailored only for Korean participants

Mahabee‐Gittens 2008

Research staff provided the intervention

Maizlish 2006

Before‐and‐after study, not meeting study design requirements

Manfredi 1999

Research staff provided adjunct interventions (motivational call and reminder letter); only brief advice provided by the clinic staff

Manfredi 2000

Research staff provided adjunct interventions (motivational call and reminder letter); only brief advice provided by the clinic staff

Manfredi 2004

Research staff provided adjunct interventions (motivational call and reminder letter); only brief advice provided by the clinic staff

Manfredi 2011

Research staff provided telephone counselling service

McFall 2010

Not all smokers included in the intervention; RCT design

Murray 2013

Research team was involved in the delivery of the intervention. Not all smokers were identified and treated

Pbert 2004

Not all smokers included in the study; women receiving prenatal care and WIC services and planning to receive paediatric care at 1 of the CHCs were eligible. Those at less than 2 months to the due date and non‐pregnant excluded

Rindal 2013

The intervention was provided only during recall dental visits. No training was provided

Roski 1998

Quasi‐experimental research design. No evidence that all smokers accessing the system were identified and treated

Sherman 2008

Intervention mainly consisted of referring to an onsite counselling programme; clinicians were not involved in the intervention.

Szatkowski 2016

Implemented only the reimbursement (pay‐for‐performance) component of the system change intervention and targeted only GPs

Szpunar 2006

No random selection of sites (controlled before‐and‐after study), not meeting study design requirements

Taggar 2012

Implemented only the reimbursement (pay‐for‐performance) component of the system change intervention and targeted only GPs

Thomas 2016

Not all smokers received intervention; RCT design; smokers were identified by a researcher

Unrod 2007

Research staff identified smokers. Not all smokers received intervention

Vidrine 2013a

Research team was involved in delivering the intervention

Vidrine 2013b

Research team was involved in delivering the intervention

Walsh 1997

Not all smokers received intervention; RCT design

Wolfenden 2005

Not all smokers received intervention; RCT design ; smokers were identified by a researcher

Yano 2008

No evidence of effort to identify and treat all smokers accessing the system

Characteristics of ongoing studies [ordered by study ID]

Bonevski 2016

Trial name or title

An organizational change intervention for increasing the delivery of smoking cessation support in addiction treatment centres: study protocol for a randomized controlled trial

Methods

Design: Cluster‐randomized clinical trial

Setting: 33 drug and alcohol treatment services in Australia

Intervention providers: all staff

Data collection: Participant surveys

Participants

People attending drug and alcohol treatment services

Interventions

Intervention includes assistance in developing smoke‐free policies, identifying all smokers, nomination of champions, staff training and educational participant and service resources, and free nicotine replacement therapy in order to integrate smoking cessation support as part of usual participant care

Outcomes

Biochemically‐verified 7‐day point prevalence abstinence at 6 weeks will be the primary outcome measure.

Starting date

02/02/15

Contact information

A/Prof Billie Bonevski, Centre for Translational Neuroscience and Mental Health, University of Newcastle, NSW, Australia

Notes

This study is a potentially included study.

Ostroff 2014

Trial name or title

Dentists United to Extinguish Tobacco (DUET): a study protocol for a cluster randomized, controlled trial for enhancing implementation of clinical practice guidelines for treating tobacco dependence in dental care settings.

Methods

Design: Cluster‐randomized clinical trial

Setting: 18 dental care clinics in the USA

Intervention providers: dentist, dental hygienist, and dental assistants

Data collection: patient exit interviews, provider surveys, site observations, chart audits

Participants

All people attending the clinic

Interventions

Intervention 1: Staff training and current best practice (CBP)
Intervention 2: CBP and provider performance training (PF)
Intervention 3: CBP, PF and provider reimbursement

Outcomes

Provider adherence to PHS guidelines, 7‐day point prevalence abstinence, 24‐hour quit attempts, provider attitudes and cost per quit

Starting date

Contact information

Notes

This study is ongoing and has a published protocol. The arm 3 may be eligible to include in this review if they make sufficient effort to identify all smokers

Study flow diagram.
Figuras y tablas -
Figure 1

Study flow diagram.

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
Figuras y tablas -
Figure 2

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
Figuras y tablas -
Figure 3

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.

Summary of findings for the main comparison. System change interventions for tobacco control

System change interventions for tobacco control (primary cessation outcome)

Patient or population: Smokers
Settings: Any healthcare delivery setting
Intervention: System change

Outcomes*

No of Participants
(studies)

Quality of the evidence
(GRADE)

Comments

Cessation outcome
Self‐reported/verified abstinence
Follow‐up: 6 to 24 months

7142
(4 studies)

⊕⊝⊝⊝
very low1,2

2 of the 4 studies significantly favoured the intervention. Mixed effect and low quality evidence preclude drawing conclusions

NB. Illustrative comparative risks and relative effects columns have been removed, as only narrative syntheses were conducted due to the presence of significant heterogeneity among studies.

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1Self‐reported abstinence was verified only in one study, and one study reported higher dropout rate in one group.
2High clinical heterogeneity among included studies; outcomes are measured at different time points, and in different settings.

Figuras y tablas -
Summary of findings for the main comparison. System change interventions for tobacco control
Summary of findings 2. System change interventions for tobacco control

System change interventions for tobacco control (secondary outcomes)

Patient or population: Smokers
Settings: Any healthcare delivery setting
Intervention: System change

Outcomes*

No of Participants
(studies)

Quality of the evidence
(GRADE)

Comments

Provision of cessation counselling
Proportion of smokers counselled to quit

10,949
(4 studies)

⊕⊕⊝⊝
low1,2,3

3 of the 4 studies significantly favoured the intervention. The low quality of the evidence precludes drawing conclusions

Asking about tobacco use
Proportion of smokers asked about tobacco use

2615
(3 studies)*

⊕⊕⊝⊝
low1,3

2 of the 3 studies significantly favoured the intervention. The low quality of the evidence precludes drawing conclusions

Provision of cessation advice
Proportion of smokers advised to quit

3003
(3 studies)*

⊕⊕⊝⊝
low1,3

2 of the 3 studies significantly favoured the intervention. The low quality of the evidence precludes drawing conclusions

Quitline referral
Proportion of smokers referred to quitline

3006
(3 studies)*

⊕⊝⊝⊝
very low1,3

All 3 studies significantly favoured the intervention. However, the low quality of the evidence precludes drawing conclusions

Quitline enrolment
Proportion of smokers enrolled in quitline

1191
(2 studies)*

⊕⊝⊝⊝
very low1,3

Both studies significantly favoured the intervention. However, the low quality of the evidence precludes drawing conclusions

Prescription of NRT or other pharmacotherapy
Proportion of smokers received NRT prescription

2615
(2 studies)

⊕⊕⊝⊝
low1,3

Of the 2 studies, 1 significantly favoured the intervention. Mixed effect and low‐quality evidence preclude drawing conclusions

NB. Illustrative comparative risks and relative effects columns have been removed, as only narrative syntheses were conducted due to the presence of significant heterogeneity among studies

*We have not included data from one study as the data were collected as counts (no denominator)

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1Included studies had high risk of detection bias.
2Large difference in effect size between studies.
3High clinical heterogeneity among included studies; different settings, providers and intervention.

Figuras y tablas -
Summary of findings 2. System change interventions for tobacco control
Table 1. Components of interventions in included studies

Identification/ documentation of smoking status

Smoking cessation Training/ resources/feedback to providers

Dedicated staff to support cessation activities

Policies to improve access to cessation interventions

Free smoking cessation treatment from the organization

Reimburse clinicians for providing smoking cessation support

Cabezas 2011

Yes

Yes

No

No

Yes

No

Gordon 2010

Yes

Yes

No

No

Yes

No

Joseph 2004

Yes

Yes

No

Yes

Yes

No

Little 2009

Yes

Yes

No

Yes

Yes

No

Patwardhan 2012

Yes

Yes

No

Yes

Yes

No

Rothemich 2010

Yes

Yes

No

Yes

Yes

No

Winickoff 2013

Yes

Yes

No

Yes

Yes

No

Figuras y tablas -
Table 1. Components of interventions in included studies
Table 2. Summary of secondary outcomes

Study

Asking about tobacco use

Documentation of smoking status

Advice to quit

Counselling to quit

Initiation of NRT or other pharmacotherapy

Quitline referral

Quitline enrolment

Cabezas 2011

Not assessed

Not assessed

Not assessed

Not assessed

Not assessed

Not assessed

Not assessed

Gordon 2010

Not assessed

Not assessed

Not assessed

Not assessed

Not assessed

Not assessed

Not assessed

Joseph 2004

No difference between groups (76.0% vs 74.3%; P = 0.71)

Favoured intervention (60.7% vs 67.0%; P < 0.001)

Not assessed

No difference between groups (73.9% vs 71.8%; P = 0.60)

No difference between groups (14.7% vs 18.0%; P = 0.38)

Not assessed

Not assessed

Little 2009

Not assessed

Not assessed

Not assessed

Favoured intervention (69% vs 3%; P < 0.01)

Not assessed

Not assessed

Not assessed

Patwardhan 2012*

Favoured intervention (636 vs 5; P < 0.001)

Not assessed

Favoured intervention (25 vs 3; P < 0.01)

Not assessed

Not assessed

Favoured intervention (240 vs 85; P = 0.02)

Favoured intervention (81 vs 8; P < 0.001)

Rothemich 2010

Not assessed

Not assessed

No difference between groups (58.2% vs 55.3%; P = 0.39).

Favoured intervention (34.4% vs 27.7%; P = 0.001)

Not assessed

Favoured intervention (21.4% vs 8.7%; P < 0.001)

Not assessed

Winickoff 2013

Favoured intervention (59.4% vs 32.6%; P < 0.001)

Not assessed

Favoured intervention (50.5% vs 26.9%; P < 0.001).

Favoured intervention (54.7% vs 19.2%; P < 0.001)

Favoured intervention (18.5% vs 2.4%; P < 0.001)

Favoured intervention (37.2% vs 9.3%; P < 0.001)

Favoured intervention (4.1% vs 1.1%; P < 0.01)

*data collected as counts (no denominator)

Figuras y tablas -
Table 2. Summary of secondary outcomes